Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Recurrent Gastrointestinal Carcinoma”

929 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 929 results

Testing effectiveness (Phase 2)Study completedNCT01262560
What this trial is testing

Manuka Honey in Preventing Esophagitis-Related Pain in Patients Receiving Chemotherapy and Radiation Therapy For Lung Cancer

Who this might be right for
DysphagiaLung CancerPain+1 more
Radiation Therapy Oncology Group 163
Early research (Phase 1)Study completedNCT03297710
What this trial is testing

TAS-102 and Radiation Therapy in Treating Patients With Rectal Cancer That Is Locally Recurrent, Metastatic, or Cannot Be Removed by Surgery

Who this might be right for
Rectal AdenocarcinomaRecurrent Rectal CarcinomaStage IV Rectal Cancer AJCC v7+2 more
Mayo Clinic 7
Testing effectiveness (Phase 2)Study completedNCT00602082
What this trial is testing

Capecitabine and Streptozocin With or Without Cisplatin in Treating Patients With Unresectable or Metastatic Neuroendocrine Tumors

Who this might be right for
Gastrointestinal Carcinoid TumorIslet Cell Tumor
Cambridge University Hospitals NHS Foundation Trust 84
Large-scale testing (Phase 3)Study completedNCT00692770
What this trial is testing

Sorafenib as Adjuvant Treatment in the Prevention Of Recurrence of Hepatocellular Carcinoma (STORM)

Who this might be right for
Carcinoma, Hepatocellular
Bayer 1,114
Testing effectiveness (Phase 2)Study completedNCT01006369
What this trial is testing

Hydroxychloroquine, Capecitabine, Oxaliplatin, and Bevacizumab in Treating Patients With Metastatic Colorectal Cancer

Who this might be right for
Colorectal Cancer
Rutgers, The State University of New Jersey 38
Testing effectiveness (Phase 2)UnknownNCT00884767
What this trial is testing

Biomarkers in Predicting Neurotoxicity in Patients With Colorectal Cancer Receiving Oxaliplatin

Who this might be right for
Chemotherapeutic Agent ToxicityColorectal CancerNeurotoxicity
Institut Cancerologie de l'Ouest 206
Not applicableStudy completedNCT00059267
What this trial is testing

Prevention of Recurrent Hepatitis B After Liver Transplantation

Who this might be right for
Hepatitis BCirrhosisAcute Liver Failure+1 more
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) 317
Not applicableStudy completedNCT00408681
What this trial is testing

Lithium Carbonate in Treating Patients With Acute Intestinal Graft-Versus-Host-Disease (GVHD) After Donor Stem Cell Transplant

Who this might be right for
Accelerated Phase Chronic Myelogenous LeukemiaAdult Acute Lymphoblastic Leukemia in RemissionAdult Acute Myeloid Leukemia in Remission+111 more
Fred Hutchinson Cancer Center 20
Testing effectiveness (Phase 2)Study completedNCT00084942
What this trial is testing

Gemcitabine and Capecitabine in Treating Patients With Advanced and/or Inoperable Cholangiocarcinoma or Carcinoma of the Gallbladder

Who this might be right for
Extrahepatic Bile Duct CancerGallbladder Cancer
Roswell Park Cancer Institute
Early research (Phase 1)Study completedNCT00083213
What this trial is testing

Intravenous VEGF Trap in Treating Patients With Relapsed or Refractory Advanced Solid Tumors or Non-Hodgkin's Lymphoma

Who this might be right for
Cancer
Regeneron Pharmaceuticals 25
Early research (Phase 1)Study completedNCT00654160
What this trial is testing

Irinotecan, Fluorouracil, and Leucovorin in Treating Patients With Advanced Gastrointestinal Cancer

Who this might be right for
Anal CancerCarcinoma of the AppendixColorectal Cancer+9 more
Mayo Clinic 7
Testing effectiveness (Phase 2)Study completedNCT00077142
What this trial is testing

TAC-101 in Treating Patients With Advanced Hepatocellular Carcinoma (Liver Cancer)

Who this might be right for
Liver Cancer
M.D. Anderson Cancer Center 37
Large-scale testing (Phase 3)UnknownNCT05250843
What this trial is testing

TACE/HAIC Combined With Lenvatinib and Sintilimab in Neoadjuvant Therapy for Intermediate-stage HCC

Who this might be right for
Hepatocellular Carcinoma
Third Affiliated Hospital, Sun Yat-Sen University 90
Not applicableLooking for participantsNCT06653062
What this trial is testing

Circulating Tumor Mitochondrial DNA (ct-mtDNA) As a Biomarker for Hepatocellular Carcinoma Recurrence Surveillance

Who this might be right for
Hepatocellular Carcinoma (HCC)
Tongji Hospital 50
Testing effectiveness (Phase 2)Study completedNCT02259725
What this trial is testing

Regorafenib in Treating Patients With Advanced or Metastatic Neuroendocrine Tumors

Who this might be right for
GastrinomaGlucagonomaInsulinoma+6 more
University of Southern California 3
Testing effectiveness (Phase 2)Study completedNCT00005049
What this trial is testing

Combination Chemotherapy in Treating Patients With Stage III Ovarian Epithelial Cancer or Gastrointestinal Cancer

Who this might be right for
Colorectal CancerGastric CancerGastrointestinal Carcinoid Tumor+4 more
NYU Langone Health 45
Testing effectiveness (Phase 2)Study completedNCT00083226
What this trial is testing

Doxorubicin and Bortezomib in Treating Patients With Liver Cancer

Who this might be right for
Adult Primary Hepatocellular CarcinomaAdvanced Adult Primary Liver CancerLocalized Unresectable Adult Primary Liver Cancer+1 more
National Cancer Institute (NCI) 42
Early research (Phase 1)Study completedNCT00019435
What this trial is testing

LMB-9 Immunotoxin in Treating Patients With Advanced Solid Tumors

Who this might be right for
Bladder CancerBreast CancerColorectal Cancer+4 more
National Cancer Institute (NCI)
Early research (Phase 1)UnknownNCT00021268
What this trial is testing

Tocladesine in Treating Patients With Recurrent or Progressive Metastatic Colorectal Cancer

Who this might be right for
Colorectal Cancer
Jonsson Comprehensive Cancer Center
Testing effectiveness (Phase 2)Ended earlyNCT01164150
What this trial is testing

Prospective Randomised Phase II Trial Evaluating Adjuvant Pelvic Radiotherapy Using Either IMRT or 3-Dimensional Planning for Endometrial Cancer. ICORG 09-06

Who this might be right for
Endometrial CancerGastrointestinal ComplicationsRadiation Toxicity+1 more
Cancer Trials Ireland 92
Next Page